Publication | Closed Access

Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial

Hematological MalignancyOncologyOverall SurvivalRelapsed Multiple MyelomaHematologyMyeloid NeoplasiaPanorama 1MedicineRadiation OncologyHealth Sciences